Wave Life Sciences Initiates Phase 2a Multidose Portion Of INLIGHT Trial, Placebo-Controlled Study Evaluating WVE-007 As Monotherapy In Individuals Living With Obesity With High BMI And Comorbidities

Loading news article.

Wave Life Sciences Initiates Phase 2a Multidose Portion Of INLIGHT Trial, Placebo-Controlled Study Evaluating WVE-007 As Monotherapy In Individuals Living With Obesity With High BMI And Comorbidities | WAPE

Wave Life Sciences Initiates Phase 2a Multidose Portion Of INLIGHT Trial, Placebo-Controlled Study Evaluating WVE-007 As Monotherapy In Individuals Living With Obesity With High BMI And Comorbidities

Article summary

Related companies

Comments —